TW202515610A - 治療克隆氏症(crohn's disease)的方法 - Google Patents

治療克隆氏症(crohn's disease)的方法 Download PDF

Info

Publication number
TW202515610A
TW202515610A TW113124301A TW113124301A TW202515610A TW 202515610 A TW202515610 A TW 202515610A TW 113124301 A TW113124301 A TW 113124301A TW 113124301 A TW113124301 A TW 113124301A TW 202515610 A TW202515610 A TW 202515610A
Authority
TW
Taiwan
Prior art keywords
weeks
dose
administered
milikizumab
treatment
Prior art date
Application number
TW113124301A
Other languages
English (en)
Chinese (zh)
Inventor
史都華 威廉 菲來得利奇
保羅 弗雷德里克 波勒克
杰 勞倫斯 圖透
Original Assignee
美商美國禮來大藥廠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商美國禮來大藥廠 filed Critical 美商美國禮來大藥廠
Publication of TW202515610A publication Critical patent/TW202515610A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
TW113124301A 2019-04-22 2020-04-14 治療克隆氏症(crohn's disease)的方法 TW202515610A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962836910P 2019-04-22 2019-04-22
US62/836,910 2019-04-22

Publications (1)

Publication Number Publication Date
TW202515610A true TW202515610A (zh) 2025-04-16

Family

ID=70554215

Family Applications (2)

Application Number Title Priority Date Filing Date
TW113124301A TW202515610A (zh) 2019-04-22 2020-04-14 治療克隆氏症(crohn's disease)的方法
TW109112447A TWI850365B (zh) 2019-04-22 2020-04-14 治療克隆氏症(crohn's disease)的方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW109112447A TWI850365B (zh) 2019-04-22 2020-04-14 治療克隆氏症(crohn's disease)的方法

Country Status (16)

Country Link
US (1) US20220040299A1 (https=)
EP (1) EP3958897A1 (https=)
JP (3) JP7297930B2 (https=)
KR (2) KR102869852B1 (https=)
CN (2) CN113677366A (https=)
AU (2) AU2020263238C1 (https=)
BR (1) BR112021018930A2 (https=)
EA (1) EA202192532A1 (https=)
IL (2) IL286818B2 (https=)
MA (1) MA55756A (https=)
MX (1) MX2021012848A (https=)
SG (1) SG11202110619XA (https=)
TW (2) TW202515610A (https=)
UA (1) UA128657C2 (https=)
WO (1) WO2020219314A1 (https=)
ZA (1) ZA202108094B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202515610A (zh) * 2019-04-22 2025-04-16 美商美國禮來大藥廠 治療克隆氏症(crohn's disease)的方法
KR20220066831A (ko) 2020-11-16 2022-05-24 엔브이에이치코리아(주) 습기경화형 접착제를 이용한 헤드라이닝 제조방법 및 이에 의해 제조되는 헤드라이닝

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR094877A1 (es) 2013-03-08 2015-09-02 Lilly Co Eli Anticuerpos que se unen a il-23
KR20150128859A (ko) 2013-03-15 2015-11-18 암젠 인크 항-il23 항체를 사용하여 크론병을 치료하는 방법
TWI811716B (zh) * 2015-09-18 2023-08-11 德商百靈佳殷格翰國際股份有限公司 治療發炎性疾病之方法
WO2018035330A1 (en) * 2016-08-19 2018-02-22 Janssen Biotech, Inc. Methods of treating crohn's disease with an anti-nkg2d antibody
CA3068673A1 (en) * 2017-07-10 2019-01-17 Rambam Med-Tech Ltd. Assays for assessing neutralizing antibodies levels in subjects treated with a biological drug and uses thereof in personalized medicine
TW202515610A (zh) * 2019-04-22 2025-04-16 美商美國禮來大藥廠 治療克隆氏症(crohn's disease)的方法

Also Published As

Publication number Publication date
EA202192532A1 (ru) 2022-01-21
JP2025148449A (ja) 2025-10-07
KR20210142704A (ko) 2021-11-25
IL324048A (en) 2025-12-01
MX2021012848A (es) 2021-12-10
JP7761614B2 (ja) 2025-10-28
JP2022530397A (ja) 2022-06-29
AU2020263238A1 (en) 2021-11-04
NZ781127A (en) 2025-06-27
CN119700968A (zh) 2025-03-28
MA55756A (fr) 2022-03-02
ZA202108094B (en) 2025-05-28
IL286818B2 (en) 2026-03-01
AU2020263238B2 (en) 2023-08-17
AU2023265759A1 (en) 2023-12-07
IL286818B1 (en) 2025-11-01
IL286818A (en) 2021-10-31
CA3134587A1 (en) 2020-10-29
SG11202110619XA (en) 2021-11-29
CN113677366A (zh) 2021-11-19
JP7297930B2 (ja) 2023-06-26
TWI850365B (zh) 2024-08-01
JP2023116680A (ja) 2023-08-22
WO2020219314A1 (en) 2020-10-29
KR20250153865A (ko) 2025-10-27
EP3958897A1 (en) 2022-03-02
UA128657C2 (uk) 2024-09-18
KR102869852B1 (ko) 2025-10-14
BR112021018930A2 (pt) 2022-01-18
TW202103734A (zh) 2021-02-01
US20220040299A1 (en) 2022-02-10
AU2020263238C1 (en) 2024-02-22

Similar Documents

Publication Publication Date Title
AU2023248103B2 (en) Methods of treating ulcerative colitis
JP2025148449A (ja) クローン病を治療する方法に使用するためのミリキズマブ
CA3134587C (en) Mirikizumab for use in a method of treating crohn's disease
EA045979B1 (ru) Мирикизумаб для применения в способе лечения болезни крона
EA049081B1 (ru) Способы лечения язвенного колита